Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel
Journal of Drugs in Dermatology · 2024
DOI: 10.36849/jdd.8246 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Drugs in Dermatology, 2024. Verfasst von Joshua Burshtein und 11 weiteren Autor:innen. Hauptthemen laut MEDLINE: Psoriasis, Consensus, Antibodies, Monoclonal, Humanized, Interleukin-17. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Burshtein, J., Shah, M., Zakria, D., Armstrong, A. W., Golant, A. K., Gottlieb, A. B., Weinberg, J. M., Kircik, L., Han, G., Langley, R. G., Neimann, A. L., & Lebwohl, M. (2024). Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8246
Vancouver
Burshtein J, Shah M, Zakria D, Armstrong AW, Golant AK, Gottlieb AB, et al. Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.8246
BibTeX
@article{Burshtein2024,
author = {Burshtein, Joshua and Shah, Milaan and Zakria, Danny and Armstrong, April W and Golant, Alexandra K and Gottlieb, Alice B and Weinberg, Jeffrey M and Kircik, Leon and Han, George and Langley, Richard G and Neimann, Andrea L and Lebwohl, Mark},
title = {Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel},
journal = {Journal of Drugs in Dermatology},
year = {2024},
doi = {10.36849/jdd.8246}
}
EUVIMED